depression

Eliem drops depression drug, ending pursuit of Biogen-Sage and laying off 55% of team
Fierce Biotech
Fri, 02/10/23 - 10:25 am
Eliem Therapeutics
depression
layoffs
ETX-155
AbbVie's Vraylar, carrying $4B sales target, wins FDA label expansion in depression
Fierce Pharma
Mon, 12/19/22 - 10:05 pm
AbbVie
Vraylar
depression
FDA
Relmada rails against depression data both 'implausible' and 'unplausible' in latest phase 3 flunk
Fierce Biotech
Thu, 12/8/22 - 10:20 am
Relmada
REL-1017
depression
clinical trials
Lusaris Launches with $60M to Advance Psychedelic-Based Depression Therapeutic
BioSpace
Thu, 11/3/22 - 11:00 am
Lusaris Therapeutics
funding
LSR-1019
depression
treatment-resistant depression
Prescriptions for mental health medications hiked during COVID-19
Beckers Hospital Review
Wed, 07/13/22 - 08:23 pm
antidepressants
depression
mental health
COVID-19
pandemic
Abbott Looks to Treat Severe Depression with DBS
Medical Devices and Diagnostics Industry
Tue, 07/12/22 - 11:27 pm
Abbott Labs
deep brain stimulation
treatment-resistant depression
depression
devices
Medtech
Axsome and Aytu's Positive Day with the FDA
BioSpace
Tue, 04/19/22 - 11:54 pm
FDA
Axsome Therapeutics
Aytu BioSciences
depression
Vascular Ehlers-Danos Syndrome
Axsome moves 'closer to judgement day' for stalled depression therapy
Fierce Biotech
Tue, 04/19/22 - 11:05 am
Axsome Therapeutics
FDA
depression
AXS-05
Neurological problems no higher after vaccination; depression, anxiety risk tied to COVID severity
Yahoo/Reuters
Mon, 03/21/22 - 10:24 am
COVID-19
vaccines
Bell's Palsy
Guillain-Barré Syndrome
anxiety
depression
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect
Fierce Biotech
Tue, 03/1/22 - 10:42 am
AbbVie
M&A
Neuroscience
Syndesi Therapeutics
UCB Pharma
Alzheimer's disease
depression
Sage claims new data show depression drug works, but doubts remain
Biopharma Dive
Wed, 02/16/22 - 11:05 pm
SAGE Therapeutics
Biogen
depression
clinical trials
zuranolone
Sage changes primary endpoint in key study months after analysts fret about depression drug's durability
Endpoints
Wed, 11/3/21 - 10:41 am
SAGE Therapeutics
clinical trials
zuranolone
depression
endpoints
SSRIs
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road
Fierce Biotech
Mon, 08/23/21 - 11:08 am
Axsome Therapeutics
depression
FDA
Go or no go? August FDA decisions for Axsome, Sanofi and Merck
EP Vantage
Fri, 07/30/21 - 11:04 am
FDA
Axsome Therapeutics
Sanofi
Merck
Pompe disease
depression
kidney cancer
Keytruda
Could These 3 Potential Blockbusters Transform Biogen?
Motley Fool
Mon, 07/26/21 - 09:04 am
Biogen
zuranolone
depression
TMS-007
stroke
Aduhelm
Alzheimer's disease
Sage Therapeutics Plunges After Depression Drug-Trial Results
TheStreet.com
Tue, 06/15/21 - 10:36 am
SAGE Therapeutics
clinical trials
depression
Biogen
zuranolone
FDA Begins Priority Review of Axsome Therapeutics' Potential New Depression Drug
Motley Fool
Mon, 04/26/21 - 11:07 pm
Axsome Therapeutics
depression
AXS-05
First-of-its-kind study pits psilocybin against a common antidepressant
Stat
Wed, 04/14/21 - 09:45 pm
psilocybin
psychedelic drugs
depression
antidepressants
Is Biogen Getting Desperate?
Motley Fool
Wed, 12/9/20 - 10:42 am
Biogen
SAGE Therapeutics
major depressive disorder
depression
Biogen bets $1.5B on Sage's once-failed depression drug
Fierce Biotech
Mon, 11/30/20 - 10:29 am
Biogen
SAGE Therapeutics
zuranolone
depression

Pages